Raymond Miralbell
机构: Professor of Medicine, University of Geneva, Switzerland
每年引用次数
引用次数
引用: 13,245
H-指数: 61
I10-指数 : 158
出版物: 471
First tests to implement an in-house 3d-printed photon bolus procedure using clinical treatment planning system data
G. Dipasquale , R. Miralbell , P. Starkov , O. Ratib
Radiotherapy and Oncology 118
2
2016
Optimizing prostate cancer irradiation: from technology to fractionation
R. Miralbell
Radiotherapy and Oncology 118
2016
Urethra-sparing SBRT for prostate cancer: dosimetric optimization with VMAT vs. IMRT and the learning curve effect
T. Zilli , Z. Symon , S. Bral , A. Bruynzeel
Radiotherapy and Oncology 118
2016
81 The dose factor in prostate cancer radiotherapy
R. Miralbell
Radiotherapy and Oncology 78
2006
200 3-D Conformal radiotherapy treatment planning for prostate cancer: Better organ definition and less dose to the penile bulb with MRI-based virtual simulation
G. Dipasquale , C. Ares , C. Jargy , P. Nouet
Radiotherapy and Oncology 78
2006
167 Endorectal mri assessment of local relapse after surgery for prostate cancer: A model to define treatment field guidelines for adjuvant post-prostatectomy radiotherapy in patients at high-risk for local failure
H. Vees , J. Lozano , H. Khan , A. Hidalgo
Radiotherapy and Oncology 78
2006
Partial Volume High-dose-rate Brachytherapy Boost for Localized Prostate Cancer: Toxicity and Outcome
U. Schick , Y. Popowski , P. Nouet , C. Ares
International Journal of Radiation Oncology*Biology*Physics 78 ( 3) S356 -S357
2010
A Multi-institutional Trial Of Rectal Dose Reduction During Prostate Radiotherapy Via Polyethylene-glycol Hydrogel Injection: Initial Results
D. Song , K. Herfarth , M. Uhl , B. van Triest
International Journal of Radiation Oncology Biology Physics 81 ( 2)
2
2011
Salvage Radiotherapy after Radical Prostatectomy: Dose-Adapted Treatment to a Target Volume Defined from Typical Patterns of Loco-regional Failure on Endorectal MRI and/or PET-CT
T. Zilli , S. Jorcano , N. Peguret , H. Vees
International Journal of Radiation Oncology Biology Physics 81 ( 2)
2011
A Limited Course Of Androgen Deprivation And High Dose Targeted Radiotherapy Of Regional And/or Distant Oligometastatic Recurrences May Prolong Biochemical Free Survival In Prostate Cancer Patients
U. Schick , S. Jorcano , P. Nouet , M. Rouzaud
International Journal of Radiation Oncology Biology Physics 81 ( 2)
2011
Single Fraction Urethra-Sparing Prostate Cancer SBRT: Phase I Results of a Multicenter, Single Arm, Phase I/II Trial
T. Zilli , C. Franzese , N. Giaj-Levra , R. Förster
International Journal of Radiation Oncology Biology Physics 105 ( 1)
2019
Is there any use in accelerated and hyperfractionated radiotherapy in locally advanced head and neck cancer
M. Monney , A. Allal , C. Guillemin , A. Rosset
European Journal of Cancer 33
1997
Excess of cardiovascular mortality among node-negative breast cancer patients irradiated for inner-quadrant tumors
C. Bouchardy , E. Rapiti , M. Usel , S. Balmer Majno
Annals of Oncology 21 ( 3) 459 -465
24
2010
Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients
A. Baskin , G. Amzalag , F. Buchegger , R. Miralbell
Nuklearmedizin-nuclear Medicine 54 ( 5) 211 -216
3
2015
The role of radiotherapy in the treatment of subtotally resected benign meningiomas.
R. Miralbell , R. M. Linggood , S. de la Monte , K. Convery
Journal of Neuro-oncology 13 ( 2) 157 -164
184
1992
965 poster PILOT STUDY OF ADJUVANT FRAMELESS STEREOTACTIC RADIOTHERAPY (FSR) TO THE SURGICAL CAVITY IN PATIENTS WITH BRAIN METASTASES.
S. Villà Freixa , C. Hostalot , D. Linero , L. Escude
Radiotherapy and Oncology 99
2011
1045 poster THE PROGNOSTIC VALUE OF EXPRESSION OF HIF 1, VEGF-A AND EGFR IN PROSTATE CANCER FOR INTERMEDIATE-RISK PATIENT TREATED WITH RADIATION THERAPY WITH OR WITHOUT ANDROGEN DEPRIVATION THERAPY.
J.C. Tille , D.C. Weber , K. Hammad , P. Granger
Radiotherapy and Oncology 99
2011
16 DOSE-FRACTIONATION SENSITIVITY OF PROSTATE CANCER
R. Miralbell
Radiotherapy and Oncology 102
2012
PD-0312 DOSE ADAPTED SALVAGE RT AFTER RADICAL PROSTATECTOMY BASED ON AN ERMRI TARGET DEFINITION MODEL: TOXICITY ANALYSIS
T. Zilli , S. Jorcano , N. Peguret , F. Caparrotti
Radiotherapy and Oncology 103
2012
EP-1126 HYPOFRACTIONATED BOOST TO THE PROSTATE AFTER WHOLE PELVIS RADIOTHERAPY FOR PATIENTS WITH HIGH-RISK PROSTATE CANCER
S. Jorcano Picart , T. Zilli , R. Miralbell
Radiotherapy and Oncology 103
2012